Genetically Engineered Salmon: From First Sales to the End of Commercial Production

When the first genetically engineered salmon went on sale in Canada in 2017, critics warned that tons of “Frankenfish” were poised to enter the food supply, possibly without consumers knowing. The fish, an Atlantic salmon engineered to grow faster, was the first genetically engineered animal approved for human consumption in the United States. Its developer promised a more efficient, land-based source of salmon that could reduce pressure on wild fish and ocean farms.

A decade later, the story ended differently than either supporters or critics predicted. The company struggled financially, sold its farms and the rights to the fish, and by 2025 had stopped producing salmon altogether. This article reviews how the salmon was engineered and approved, the environmental and health questions it raised, why many retailers refused to sell it, what happened to the company, and what consumers should know about salmon choices today.

Is genetically engineered salmon safe, and is it still sold? The FDA approved AquaBounty’s GE salmon in 2015 as safe to eat and nutritionally equivalent to conventional salmon. The fish grows faster by carrying a growth-hormone gene that stays active year-round. After years of retailer resistance and labeling fights, the company stopped producing it in 2024 for business reasons, not safety. So while approved and sold for a time, GE salmon is no longer actively farmed by the company.

How Was the Salmon Genetically Engineered?

AquaBounty’s salmon carries a growth-hormone gene from Chinook salmon plus a genetic switch from another fish, so it produces growth hormone year-round and reaches market size in about half the usual time. The fish, marketed as AquAdvantage salmon, was created in the late 1980s and early 1990s by inserting a growth hormone gene from Chinook salmon, linked to a promoter sequence from ocean pout, an eel-like fish, into Atlantic salmon. Normally, Atlantic salmon produce growth hormone mainly during warmer months; the inserted promoter keeps the gene active year-round, allowing the fish to grow faster and reach market size in roughly half the time of conventional farmed Atlantic salmon. The company that developed it obtained exclusive licensing rights to the gene construct in 1996. To reduce environmental risks, the company produced all-female, sterile (triploid) fish and raised them in land-based tanks rather than ocean net pens.

A Long Road to Approval

The FDA reviewed the salmon under its rules for animal drugs, since the inserted gene was regulated as a new animal drug. The review took nearly two decades. In November 2015, the FDA approved the salmon, concluding that it was as safe to eat as conventional Atlantic salmon and that, given the containment measures, it was unlikely to have significant environmental impacts. Canada approved it for food in 2016. Congress then directed the FDA to delay sales until labeling guidelines were developed, and the FDA lifted an import alert in 2019 after the national bioengineered food disclosure standard was adopted. The first U.S.-raised engineered salmon was harvested in Indiana in 2021.

What Were the Environmental Concerns?

Critics worried GE salmon could escape and harm wild populations, so the fish were raised in land-based tanks and engineered to be sterile females to minimize breeding risk if any escaped. Scientists and environmental groups raised concerns about what could happen if engineered salmon escaped and interacted with wild fish. A 1999 modeling study in the Proceedings of the National Academy of Sciences by William Muir and Richard Howard proposed the “Trojan gene” hypothesis: if a transgene gave larger fish a mating advantage but reduced offspring survival, it could spread through a wild population and potentially drive it toward extinction. This study, based on experiments with a different fish species, became influential in debates about transgenic fish.

Later experiments tested these risks directly. A 2013 study in the Proceedings of the Royal Society B by Krista Oke and colleagues at Memorial University of Newfoundland showed that growth hormone transgenic Atlantic salmon could hybridize with wild brown trout and pass on the transgene. The transgenic hybrids were viable and grew faster than other crosses in hatchery-like conditions, and in stream simulations they suppressed the growth of transgenic and non-transgenic salmon by 82 and 54 percent, respectively. On the other hand, a 2011 study in Evolutionary Applications by Darek Moreau and colleagues found that captively reared transgenic male salmon were outcompeted by wild males in spawning trials, suggesting that transgenic fish might not readily spread their genes if they escaped. These studies helped explain why regulators required sterile, land-based production.

Is Genetically Engineered Salmon Safe to Eat?

The FDA concluded after extensive review that the GE salmon is as safe to eat and as nutritious as conventional Atlantic salmon, finding no meaningful differences in composition or safety. The FDA concluded that food from the engineered salmon was as safe as food from conventional Atlantic salmon, with comparable nutrition. Critics raised questions about allergenicity and growth hormone levels, arguing that some studies submitted to regulators had small sample sizes. The inserted gene produces salmon growth hormone, the same protein Chinook salmon naturally make, and fish growth hormone is not active in humans. Research comparing growth hormone transgenesis and domestication offers context: a 2009 study in the Proceedings of the National Academy of Sciences by Robert Devlin and colleagues found that domestication and growth hormone transgenesis caused similar changes in gene expression in coho salmon, suggesting that engineered fast growth works through pathways also altered by conventional selective breeding.

Why Did Retailers and Consumers Resist It?

Many grocery chains pledged not to sell GE salmon amid consumer skepticism and “Frankenfish” branding, limiting its market even after approval and contributing to the company’s commercial struggles. Even before the salmon reached market, consumer and environmental groups campaigned against it, and many major U.S. grocery chains and seafood companies pledged not to sell genetically engineered salmon. Polls consistently showed that most Americans wanted genetically engineered foods labeled, and many said they would not knowingly eat engineered fish. Some states, including Alaska, home to a large wild salmon industry, required or sought labeling. Under the national bioengineered food disclosure standard, engineered salmon sold at retail must carry a disclosure, though restaurants and food service are generally exempt, meaning diners could eat it without knowing. In practice, the limited supply was sold mostly through distributors to restaurants and food service outlets rather than grocery stores.

Why Did the Company Stop Producing GE Salmon?

AquaBounty halted production in 2024 due to financial difficulties and the high cost of its facilities, not because of any safety problem, ending commercial farming of the GE salmon for the time being. The company’s business model depended on building large land-based recirculating aquaculture farms, which are expensive to construct and operate. As Salmon Business reported in 2025, the company paused construction of a large Ohio farm in 2023 as costs rose sharply with inflation, sold its Indiana grow-out farm in July 2024, closed its Canadian farms, and sold its Canadian subsidiary, including broodstock farms in Prince Edward Island and the intellectual property for the engineered salmon, in March 2025. It reported no revenue in the second quarter of 2025 after discontinuing farming operations and reduced its staff to a small core team, focusing on selling assets and exploring options for the Ohio site. Retailer boycotts, consumer skepticism, high production costs, and competition from conventional farmed salmon all contributed to the company’s difficulties.

Farmed Salmon Concerns Beyond Genetic Engineering

Debates about engineered salmon often overlapped with broader concerns about salmon farming. A 2004 study in Science by Ronald Hites and colleagues analyzed more than two metric tons of farmed and wild salmon and found significantly higher concentrations of organochlorine contaminants, such as PCBs and dioxins, in farmed salmon than in wild salmon, with the highest levels in European farmed fish. Feed formulations have changed since then, and contaminant levels in farmed salmon have generally declined, but the study prompted ongoing attention to feed quality. Ocean net-pen farming also raises concerns about sea lice, disease transmission to wild salmon, escapes, and pollution. Land-based farming, the approach used for the engineered salmon, avoids some of these issues but requires large amounts of energy and capital.

The Health Benefits of Eating Fish

Concerns about engineered or farmed salmon should not obscure the health benefits of eating fish. A 2006 review in JAMA by Dariush Mozaffarian and Eric Rimm concluded that modest fish consumption, about one to two servings per week, especially of species rich in omega-3 fatty acids such as salmon, reduces the risk of coronary death by about 36 percent and total mortality by about 17 percent. They found that the benefits of fish intake exceed the potential risks from contaminants for most people, while advising women of childbearing age and young children to choose fish lower in mercury. Salmon is generally low in mercury and high in omega-3s, making it a good choice whether wild or responsibly farmed.

Choosing Salmon Today

Option	Notes
Wild Alaskan salmon	Sockeye, coho, pink, chum, and king; well-managed fisheries; often sold frozen or canned
Responsibly farmed Atlantic salmon	Look for third-party certifications for aquaculture practices
Land-based farmed salmon	Avoids ocean net pen issues; production still limited
Canned salmon	Affordable, usually wild, includes calcium if bones are retained
Genetically engineered salmon	Commercial production has stopped; must carry a bioengineered disclosure if sold at retail

Gene-Edited Fish Elsewhere

While the transgenic salmon venture faltered, other countries have approved gene-edited fish produced without inserting foreign genes. Japan approved gene-edited red sea bream with more muscle and fast-growing tiger puffer fish for sale in 2021, treating them differently from transgenic organisms under its regulations. These products have been sold in limited quantities. Gene-edited fish raise many of the same questions about escapes, labeling, and consumer acceptance as transgenic fish, and regulators in different countries continue to develop approaches to them.

What the Salmon’s Story Reveals

The engineered salmon’s trajectory, nearly 20 years of regulatory review followed by about a decade of limited sales and financial struggle, shows that regulatory approval is only one hurdle for genetically engineered foods. Market acceptance, retailer decisions, production costs, and investor confidence also determine success. Consumer resistance and boycotts appear to have played a meaningful role, unusual for a single food product. At the same time, the high costs of land-based aquaculture proved a major obstacle independent of public opinion. The case is likely to inform how future engineered and gene-edited animals are developed and marketed.

Wild Salmon and Their Habitat

Wild salmon populations face many pressures, including dams, habitat loss, warming waters, overfishing in some regions, and interactions with farmed fish. Some Pacific salmon runs are listed as threatened or endangered, while Alaska’s fisheries remain among the best managed in the world. Wild Atlantic salmon have declined dramatically across much of their range. Concerns about engineered salmon escaping were partly concerns about adding another stress to already vulnerable wild populations. Supporting habitat restoration and sustainable fisheries management protects wild salmon regardless of what happens with aquaculture technology.

Labeling and Restaurant Loopholes

Labeling was central to public concern about engineered salmon. The national bioengineered disclosure standard requires retail labeling through text, a symbol, or a QR code, but food service, including restaurants, cafeterias, and many prepared foods, is largely exempt. Because the engineered salmon was sold mostly through food service channels, many people who ate it likely did not know. Consumer advocates argued that this undermined informed choice, while industry groups noted that the fish had been found safe. People who want to avoid engineered fish can ask restaurants about their salmon sources, though with production halted, the question is now largely moot.

Efficiency Claims and Sustainability

Supporters argued that faster-growing salmon would use feed more efficiently, reduce production time, and allow salmon to be raised closer to consumers in land-based systems, reducing transportation emissions and pressure on wild stocks. Critics countered that land-based systems require substantial energy for pumping, filtration, and temperature control, and that salmon still depend on feed containing fish meal and fish oil or plant ingredients. The commercial failure means these sustainability claims were never tested at scale, though land-based aquaculture of conventional salmon continues to develop.

A Balanced View

The genetically engineered salmon was found safe to eat by regulators and was raised under containment designed to minimize environmental risks, while research showed that escapes could, in theory, harm wild fish through hybridization and competition. Strong consumer and retailer resistance, labeling gaps, and the high cost of land-based farming limited its success, and by 2025 commercial production had stopped. The experience offers lessons for future engineered and gene-edited animals: safety reviews alone do not ensure acceptance, and transparency and economic viability matter as much as technology.

Practical Takeaways

Eat fish, including salmon, once or twice a week for heart health. Choose wild Alaskan salmon, canned salmon, or responsibly farmed salmon with third-party certification. Check labels for bioengineered disclosures if you want to avoid engineered foods, and ask restaurants about their seafood sources. Support policies that protect wild salmon habitat.

Omega-3s in Farmed and Wild Salmon

Both farmed and wild salmon are rich sources of the omega-3 fatty acids EPA and DHA, though levels vary with diet. Farmed salmon traditionally contained high omega-3 levels from fish oil in feed, but as feed formulations shifted toward plant ingredients to reduce reliance on wild fish, omega-3 content in some farmed salmon declined. Wild salmon omega-3 content depends on species and season. Both types remain among the best dietary sources of these fats, which support heart and brain health. For people who do not eat fish, plant sources provide ALA omega-3s, which the body converts to EPA and DHA only in small amounts.

Animal Welfare Questions

Fast growth in engineered and selectively bred animals can raise welfare concerns, including deformities and health problems. Studies of growth hormone transgenic fish in research settings have reported higher rates of some abnormalities in certain lines, while developers reported acceptable health in commercial fish under managed conditions. Land-based farming allows greater control over water quality and disease but involves high stocking densities. Welfare standards for farmed fish are less developed than for land animals, and consumers concerned about welfare can look for certifications that include fish welfare criteria.

Questions to Ask About Seafood

Where was this fish caught or raised? Is it wild or farmed, and if farmed, in ocean pens or on land? Is it certified by a recognized sustainability program? Is it genetically engineered or gene-edited, and is that disclosed? How fresh is it, and was it frozen? Asking these questions at grocery stores and restaurants encourages transparency and helps consumers align purchases with their health, environmental, and ethical values.

Regulating Animals Like Drugs

In the United States, genetic changes intentionally introduced into animals were regulated by the FDA as new animal drugs, a framework critics considered ill-suited to food animals. Developers had to show that the inserted gene was safe for the animal, that food from the animal was safe, and that the modification performed as claimed, while environmental assessments addressed risks of escape. The process was lengthy and expensive, which supporters of biotechnology argued discouraged innovation and critics viewed as appropriately cautious. Policymakers have since debated shifting some oversight of genetically engineered and gene-edited food animals to the USDA, reflecting ongoing uncertainty about how best to regulate these products.

The Global Salmon Industry

Most of the world’s farmed Atlantic salmon comes from Norway and Chile, followed by Scotland, Canada, and the Faroe Islands, primarily from ocean net pens. The United States imports most of the salmon it consumes. Land-based farming promised to reduce imports and bring production closer to U.S. consumers. Several companies are building or operating land-based salmon farms with conventional fish, and their experience will show whether this approach can compete economically. The engineered salmon’s difficulties highlight the financial risks of land-based aquaculture, even without the added challenge of consumer resistance to genetic engineering.

Why Food Animals Provoke Strong Reactions

Genetically engineered animals tend to provoke stronger public reactions than engineered plants. Surveys show that people are generally more uncomfortable with genetic modification of animals, perhaps because of concerns about animal welfare, the perceived naturalness of food animals, and feelings of disgust. These reactions help explain why the first engineered food animal met organized resistance from retailers and consumers despite regulatory approval. Future developers of engineered or gene-edited animals are likely to face similar challenges unless they can demonstrate clear benefits, such as disease resistance or improved welfare, that resonate with consumers.

Looking Ahead

With commercial production of the engineered salmon halted, attention has shifted to gene-edited animals, such as disease-resistant pigs and heat-tolerant cattle, and to conventional land-based aquaculture. Regulatory frameworks continue to evolve. The salmon’s history will likely be cited for years as an example of how science, regulation, markets, and public opinion interact in determining the fate of new food technologies. For shoppers, the practical choices remain straightforward: eat fish regularly, choose wild or responsibly farmed salmon, and use labels and questions to find the products that match their values.

Mercury and Other Considerations

Salmon is among the lowest-mercury fish commonly eaten, which makes it a recommended choice for pregnant women and young children, who are advised to limit high-mercury species such as swordfish, king mackerel, and some tuna. Federal advice encourages pregnant and breastfeeding women to eat two to three servings per week of fish lower in mercury. Cooking methods also matter: baking, broiling, or grilling salmon preserves its benefits better than deep-frying. People with fish allergies should avoid salmon regardless of how it was produced.

Why the Original Fears Did Not Come True

Early warnings that tons of engineered salmon would quietly flood the market did not materialize. Production remained small, sales were limited mainly to food service, many retailers refused to carry it, and the company ultimately stopped farming. Concerns about escape into the wild were addressed through sterile fish and land-based tanks, and no establishment of engineered salmon in the wild has been documented. However, concerns about labeling gaps in restaurants were valid, and the broader questions about engineered animals remain relevant as new products are developed.

Lessons for Consumers

The salmon’s story shows that consumers have real influence over which food technologies succeed. Organized campaigns persuaded major retailers to refuse the product, and many shoppers made clear they wanted labeling. For people who care about how their food is produced, staying informed, asking questions, and supporting transparency measures can shape markets. At the same time, decisions are most useful when grounded in evidence about safety, environmental impacts, and nutrition rather than fear alone.

Common Myths

“Engineered salmon is flooding grocery stores.” Sales were limited, mostly to food service, and commercial production has stopped.

“Engineered salmon contains human growth hormone.” It contains a salmon growth hormone gene, and fish growth hormone is not active in humans.

“All farmed salmon is genetically engineered.” Nearly all farmed salmon is conventionally bred, not genetically engineered.

“Escaped engineered salmon have invaded the wild.” The commercial fish were sterile females raised on land; no wild establishment has been documented.

“Farmed salmon is unsafe to eat.” Health benefits of fish generally outweigh contaminant risks for most people.

Key Terms

Transgenic: Containing a gene from another species.

Triploid: Having three sets of chromosomes, which makes fish sterile.

Recirculating aquaculture system (RAS): Land-based tanks that filter and reuse water.

Promoter: A DNA sequence that controls when and where a gene is active.

Bioengineered disclosure: The U.S. labeling standard for foods with detectable genetically engineered material.

The Bottom Line

The first genetically engineered animal approved for food in the United States, a fast-growing Atlantic salmon, was approved in 2015 after nearly two decades of review, first sold in Canada in 2017, and harvested in the United States in 2021. Regulators found it safe to eat, and production used sterile females in land-based tanks to limit environmental risks, though studies showed transgenic salmon could hybridize with wild trout and outcompete other fish under experimental conditions. Retailer boycotts, consumer skepticism, labeling gaps, and high costs contributed to the company selling its farms and the fish’s intellectual property by March 2025 and halting production. For consumers, salmon remains a healthy choice, and wild-caught or responsibly farmed options are widely available.

Frequently Asked Questions

Is genetically engineered salmon still sold?

Not actively. AquaBounty, the company behind the FDA-approved GE salmon, stopped producing it in 2024 due to financial difficulties and the cost of running its facilities, not because of safety concerns. The salmon was approved and sold in limited quantities for a few years, but it is no longer being farmed commercially by the company, so it is largely unavailable now.

Is GE salmon safe to eat?

Yes, according to regulators. After an extensive, years-long review, the U.S. FDA concluded that AquaBounty’s genetically engineered salmon is as safe to eat and as nutritious as conventional Atlantic salmon, with no meaningful differences in composition. No evidence has emerged that the fish poses health risks to people who eat it, and it met the same safety standards as other foods.

How is the salmon genetically modified?

The salmon carries a growth-hormone gene from Chinook salmon combined with a genetic “switch” from an eel-like fish called the ocean pout. Together these keep growth hormone active year-round rather than only in warm months, so the salmon grows to market size in roughly half the time of conventional salmon, using less feed, while reaching the same final size.

Could GE salmon harm wild salmon populations?

To minimize that risk, AquaBounty raised the fish in land-based, contained tanks rather than ocean pens, and engineered them to be sterile, all-female fish. These measures were designed so that even if a fish escaped, it could not breed with or outcompete wild salmon. Critics still raised concerns, but the containment and sterility were central to the FDA’s environmental review.

Why did “Frankenfish” branding matter?

Opponents labeled the GE salmon “Frankenfish,” tapping into consumer unease about genetic engineering. This framing, along with campaigns for mandatory labeling, led many major grocery chains to pledge not to carry the salmon. The resulting lack of retail access limited the fish’s market even after FDA approval, showing how public perception and marketing can shape a product’s fate as much as regulation.

References

1. Muir WM, Howard RD. Possible ecological risks of transgenic organism release when transgenes affect mating success: sexual selection and the Trojan gene hypothesis. Proceedings of the National Academy of Sciences of the USA. 1999;96(24):13853–13856. PMID 10570162
2. Oke KB, Westley PA, Moreau DT, Fleming IA. Hybridization between genetically modified Atlantic salmon and wild brown trout reveals novel ecological interactions. Proceedings of the Royal Society B. 2013;280(1763):20131047. PMID 23720549
3. Moreau DT, Conway C, Fleming IA. Reproductive performance of alternative male phenotypes of growth hormone transgenic Atlantic salmon (Salmo salar). Evolutionary Applications. 2011;4(6):736–748. PMID 25568019
4. Devlin RH, Sakhrani D, Tymchuk WE, et al. Domestication and growth hormone transgenesis cause similar changes in gene expression in coho salmon (Oncorhynchus kisutch). Proceedings of the National Academy of Sciences of the USA. 2009;106(9):3047–3052. PMID 19223591
5. Hites RA, Foran JA, Carpenter DO, et al. Global assessment of organic contaminants in farmed salmon. Science. 2004;303(5655):226–229. PMID 14716013
6. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15):1885–1899. PMID 17047219
7. Salmon Business. AquaBounty shifts strategy following Indiana and Canada exits. August 2025. salmonbusiness.com

Last updated: October 6, 2026